×
返回 Agenda
Session 7, Track A: Optimizing Product Lifecycle in LATAM - Aligning Global Trends for Sustainable Access and Availability
Session Chair(s)
Maria Antonieta Roman
Head Regulatory Policy LaCan, Novartis, Mexico
Sara Glenn Tylosky, MBA
Chief Executive Officer, Farmacon Global, United States
Session 7, Track A: Optimizing Product Lifecycle in LATAM - Aligning Global Trends for Sustainable Access and Availability
Learning Objective : • Analyze the impact of international standards (WHO, ICH Q12) on regional Life Cycle Management (LCM) efficiency and regulatory convergence. • Evaluate the implementation of global trends, such as PACMPs and reliance pathways, to streamline post-approval changes. • Learn from regional regulatory updates to align lifecycle strategies with the goal of ensuring pharmaceutical availability.
Speaker(s)
Representative Invited
Latam Regulatory Policy Lead , Roche, Brazil
Optimizing Pharmaceutical Lifecycle: Bridging Global Trends and Regional Convergence for Sustained Product Availability